Organon & Co.

OGN

Market Cap$5.25B

Close$

Compare Organon

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Organon & Co.	5	6.64%	2181%	0.9	181.5
Market Avg	54.3	1.27%	32%	-	1.3
Healthcare Avg	39.1	1.36%	17%	7.2	1.3

$24.00

Target Price by Analysts

14.6% upsideOrganon Target Price Details

$38.19

Current Fair Value

82.4% upside

Undervalued by 82.4% based on the discounted cash flow analysis.

Share Statistics

Market cap	$5.25 Billion
Enterprise Value	$13.39 Billion
Dividend Yield	$1.3556 (6.64%)
Earnings per Share	$4.08
Beta	0.0
Outstanding Shares	257,170,727
Avg 30 Day Volume	2,461,718

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	5.02
PEG	36.99
Price to Sales	0.87
Price to Book Ratio	-
Enterprise Value to Revenue	2.11
Enterprise Value to EBIT	9.94
Enterprise Value to Net Income	12
Total Debt to Enterprise	0.65
Debt to Equity	181.54

Revenue Sources

No data

ESG Score

No data

About Organon & Co.